Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
25.52M | 24.19M | 18.60M | 18.47M | 19.21M | 14.06M | Gross Profit |
3.02M | 10.29M | -2.40M | 1.01M | 1.86M | 650.64K | EBIT |
-44.71M | -38.92M | -34.07M | -18.97M | -15.74M | -12.82M | EBITDA |
-27.09M | -19.52M | -25.03M | -12.69M | -11.19M | -9.32M | Net Income Common Stockholders |
-24.76M | -25.26M | -23.19M | -16.34M | -9.11M | -7.08M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
47.80M | 42.96M | 74.47M | 24.98M | 15.13M | 11.08M | Total Assets |
113.21M | 112.40M | 127.51M | 61.21M | 51.62M | 42.76M | Total Debt |
2.40M | 3.26M | 1.32M | 1.47M | 1.29M | 684.20K | Net Debt |
-45.40M | -39.70M | -73.15M | -23.51M | -13.84M | -10.40M | Total Liabilities |
18.97M | 28.39M | 22.55M | 16.41M | 13.48M | 16.53M | Stockholders Equity |
93.33M | 83.79M | 103.73M | 43.49M | 38.15M | 26.23M |
Cash Flow | Free Cash Flow | ||||
-32.66M | -33.13M | -30.29M | -12.76M | -15.06M | 3.68M | Operating Cash Flow |
-15.17M | -13.68M | -17.26M | -3.74M | -8.12M | 10.25M | Investing Cash Flow |
-14.71M | -17.55M | -13.03M | 13.83M | -6.94M | -16.19M | Financing Cash Flow |
17.91M | -280.00K | 79.77M | -232.33K | 19.11M | 12.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $2.41B | 12.98 | 4.78% | 5.90% | -13.90% | 0.56% | |
73 Outperform | AU$663.44M | 101.69 | 11.59% | ― | 9.76% | -28.92% | |
56 Neutral | $3.03B | 32.92 | 2.70% | 3.83% | 6.43% | ― | |
51 Neutral | $2.02B | -1.14 | -21.36% | 3.64% | 2.88% | -30.57% | |
48 Neutral | $52.89M | ― | -19.25% | ― | ― | 65.04% | |
47 Neutral | AU$66.54M | ― | -26.71% | ― | 15.24% | 8.35% | |
40 Underperform | AU$45.72M | ― | -16.88% | ― | -67.72% | 65.78% |
Calix Limited announced that its subsidiary, Leilac, is scaling back its U.S. projects due to ongoing reviews of government spending by the Trump administration. The uncertainty surrounding U.S. Department of Energy funding has led Leilac to reduce resources and costs to maintain a cash-neutral position. Despite this, Calix and Leilac are prepared to expand their project capacity in the U.S. once funding is confirmed, while continuing to focus on opportunities in Europe and Asia Pacific.
The most recent analyst rating on (AU:CXL) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Calix Ltd. stock, see the AU:CXL Stock Forecast page.
Calix Limited announced an upcoming webinar hosted by Sharewise, where CEO Phil Hodgson will provide an overview of the company. This event aims to introduce Calix’s operations and technology to a broader audience, reflecting the company’s commitment to addressing global decarbonisation challenges and enhancing its industry positioning.
The most recent analyst rating on (AU:CXL) stock is a Hold with a A$0.80 price target. To see the full list of analyst forecasts on Calix Ltd. stock, see the AU:CXL Stock Forecast page.
Calix Limited announced that its water treatment products sold in the U.S. are exempt from the tariffs imposed by the Trump administration, due to compliance with the United States-Mexico-Canada Agreement (USMCA). This exemption is significant for Calix as its Magnesia business, which heavily relies on U.S. sales, constitutes a major portion of the company’s revenue. The exemption positions Calix favorably in the U.S. market, especially given the country’s reliance on magnesia imports, predominantly from China, which are subject to tariffs.